Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of teriparatide (PTH 1-34) on fracture healing in vivo
2008-000094-37Phase 2Terminated
- Sponsor
- Rigshospitalet Glostrup
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of teriparatide in osteoporosis, trochanteric fracture and Humeral neck fracture, sponsored by Rigshospitalet Glostrup. Primary endpoint: Callus formation area on X-ray. Started Feb 2008; status: terminated.
02
Drugs
teriparatide
03
Conditions
osteoporosistrochanteric fractureHumeral neck fracture
Beyond the preview
Go deeper on 2008-000094-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000094-37.